Sunday, April 28, 2024
4/28/2024
PROJECT SUMMARY/ABSTRACT Alphaviruses are arthropod-transmitted viruses that cause acute febrile illness in humans, with some cases causing long-term skeletomuscular and neurological sequelae. Currently there are no FDA-approved vaccines or therapeutics for alphavirus infection, and continued global outbreaks of chikungunya and Eastern equine encephalitis virus highlight the need for medical countermeasures. Effective antiviral treatments target key viral replication processes without host side-effect are built on the foundational knowledge of viral replication as evidenced by the rapid development of RNA polymerase and viral protease inhibitors towards SARS-CoV-2 during the COVID-19 pandemic. While alphaviruses have been studied for decades, there are many foundational gaps in our understanding of their biology. Like all viruses, alphavirus infection of host cells induces a multifaceted innate immune response, of which one result is the activation of the integrated stress response (ISR) through viral double-stranded RNA sensing by host protein kinase R (PKR) and subsequent phosphorylation of translation initiation factor 2 (eIF2a), causing shutoff of global protein translation. However, alphaviruses have evolved a mechanism by which their structural proteins are uniquely still efficiently translated from the viral subgenomic RNA (sgRNA) during ISR activation. While many canonical translation initiation factors have been ruled dispensable for sgRNA translation, the mechanism of sgRNA translation is yet to be described. Interestingly, the resistance of the sgRNA to the ISR is only observed in infected cells, suggesting viral factors are necessary. Other work has shown that viral nonstructural protein nsP3 interacts with components of stress granules, organelles formed during ISR activation to sequester translation machinery until relief of the stress and return to homeostasis, suggesting a role for nsP3 in modulating translation during alphavirus infection-induced ISR. Together, this leads to the hypothesis that alphaviruses evade the ISR through recruitment of non-canonical initiation factors or the ribosome directly, and that ISR resistance is mediated in part through interactions of the nsP3 and host proteins. Using Sindbis virus (SINV) as a model system, this proposal seeks to identify how alphaviruses evade the ISR to maintain translation of viral structural proteins with hopes of identifying druggable targets to prevent alphavirus replication and spread. Aim 1 seeks to identify translation initiation factors responsible for sgRNA translation during ISR activation and eIF2a phosphorylation. Aim 2 will address the role of viral factors, specifically the hypervariable domain (HVD) of nsP3, in modulating the ISR and sgRNA translation through use of deep mutational scanning methods. Successful completion of this proposed work will provide mechanistic insight for an under-characterized phenomenon observed for decades in alphavirus research, allowing for novel therapeutic interventions for alphavirus infections.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
